Boston Keratoprosthesis: Outcomes and Complications: A Report by the American Academy of Ophthalmology.

OBJECTIVE To review the published literature on safety and outcomes of the Boston type I keratoprosthesis (BI-KPro) for the surgical treatment of corneal opacification not amenable to human cadaveric corneal transplantation. METHODS Searches of peer-reviewed literature were conducted in PubMed and the Cochrane Library in December 2012, July 2013, and January 2014 without date restrictions. The searches were limited to studies published in English and yielded 587 citations. The abstracts of these articles were reviewed, 48 articles were selected for possible clinical relevance, and 22 were determined to be relevant for the assessment objectives. Nine studies were rated as level II evidence and 13 studies were rated as level III evidence. Excluded were level III evidence, case reports, review articles, letters, editorials, and case series with fewer than 25 eyes. RESULTS In 9 articles, a best-corrected Snellen visual acuity (BCSVA) of 20/200 or better occurred in 45% to 89% of eyes. Five articles described a BCSVA of 20/50 or better in 43% to 69% of eyes, and 4 articles found a BCSVA of 20/40 or better in 11% to 39% of eyes. Retention rates of the BI-KPro ranged from 65% to 100%. Reasons for loss of vision after BI-KPro implantation most commonly included corneal melts resulting from exposure keratopathy, endophthalmitis, and infectious keratitis or corneal ulceration. The 2 most common complications after surgery were retroprosthetic membrane formation (range, 1.0%-65.0%; mean ± standard deviation [SD], 30.0±19.0%) and elevated intraocular pressure (range, 2.4%-64.0%; mean ± SD, 27.5±18.1%). The 2 most common posterior segment complications were endophthalmitis (range, 0%-12.5%; mean ± SD, 4.6±4.6%) and vitritis (range, 0%-14.5%; mean ± SD, 5.6±4.7%). CONCLUSIONS The reviewed articles on BI-KPro use suggest that the device improves vision in cases of severe corneal opacification that were not amenable to corneal transplantation using human cadaveric keratoplasty techniques. A number of severe anterior and posterior segment complications can develop as follow-up continues, making ongoing close observation paramount for patients undergoing this surgery. These complications include infection, device extrusion, and permanent vision loss.

[1]  M. Durand,et al.  Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. , 2001, Archives of ophthalmology.

[2]  M. Klufas,et al.  The Boston Keratoprosthesis , 2010, International ophthalmology clinics.

[3]  Ying Qian,et al.  Keratoprosthesis: Current Techniques , 2006, Cornea.

[4]  B. Khan,et al.  Management of vitreoretinal complications in eyes with permanent keratoprosthesis. , 2002, Archives of ophthalmology.

[5]  E. Cohen,et al.  Boston Keratoprosthesis Outcomes and Complications , 2009, Cornea.

[6]  D. Caldwell,et al.  The soft keratoprosthesis. , 1997, Transactions of the American Ophthalmological Society.

[7]  B. Falsini,et al.  Detection of glaucomatous damage in patients with osteo-odontokeratoprosthesis. , 1995, The British journal of ophthalmology.

[8]  M. Doane,et al.  Keratoprosthesis: Preoperative Prognostic Categories , 2001, Cornea.

[9]  Michael W. Belin,et al.  Retention of the Boston keratoprosthesis type 1: multicenter study results. , 2013, Ophthalmology.

[10]  J. Brandt,et al.  Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis. , 2011, American journal of ophthalmology.

[11]  M. Harissi-Dagher,et al.  The Role of Soft Contact Lenses as an Adjunct to the Boston Keratoprosthesis , 2008, International ophthalmology clinics.

[12]  M. Durand,et al.  Sudden Reversible Vitritis After Keratoprosthesis: An Immune Phenomenon? , 2005, Cornea.

[13]  M. Belin,et al.  Results from the multicenter Boston Type 1 Keratoprosthesis Study. , 2006, Ophthalmology.

[14]  E. Myrowitz,et al.  Short-term visual outcomes of Boston type 1 keratoprosthesis implantation. , 2010, Ophthalmology.

[15]  M. Doane,et al.  Some Factors Influencing Outcome After Keratoprosthesis Surgery , 1994, Cornea.

[16]  M. Durand,et al.  Successful Prevention of Bacterial Endophthalmitis in Eyes with the Boston Keratoprosthesis , 2009, Cornea.

[17]  A. C. Brown,et al.  Keratoprosthesis. Results, complications, and management. , 1982, Ophthalmology.

[18]  I. Schwab,et al.  Boston Type 1 Keratoprosthesis: The University of California Davis Experience , 2009, Cornea.

[19]  M. Harissi-Dagher,et al.  Boston type 1 keratoprosthesis: the CHUM experience. , 2011, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[20]  M. Durand,et al.  Fungal Colonization and Infection in Boston Keratoprosthesis , 2007, Cornea.

[21]  W STONE,et al.  Experimental study of plastic material as replacement for the cornea; a preliminary report. , 1953, American journal of ophthalmology.

[22]  P. Netland,et al.  Glaucoma associated with keratoprosthesis. , 1998, Ophthalmology.

[23]  E. Holland,et al.  Infectious Keratitis After Boston Type 1 Keratoprosthesis Implantation , 2012, Cornea.

[24]  F. Yu,et al.  International results with the Boston type I keratoprosthesis. , 2012, Ophthalmology.

[25]  M. Mannis,et al.  Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. , 2011, Ophthalmology.

[26]  F. Yu,et al.  The Boston type I keratoprosthesis: improving outcomes and expanding indications. , 2009, Ophthalmology.

[27]  S. Schwartz,et al.  POSTOPERATIVE POSTERIOR SEGMENT COMPLICATIONS IN EYES TREATED WITH THE BOSTON TYPE I KERATOPROSTHESIS , 2013, Retina.

[28]  Danish M. Khan,et al.  Advances in Boston Keratoprosthesis: Enhancing Retention and Prevention of Infection and Inflammation , 2007, International ophthalmology clinics.

[29]  F. Yu,et al.  The Boston Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency , 2011, Cornea.

[30]  I. Constable,et al.  AlphaCor™ Cases: Comparative Outcomes , 2003, Cornea.

[31]  F. Yu,et al.  Microbial keratitis after Boston type I keratoprosthesis implantation: incidence, organisms, risk factors, and outcomes. , 2013, Ophthalmology.

[32]  I J Constable,et al.  Keratoprostheses: advancing toward a true artificial cornea. , 1997, Survey of ophthalmology.

[33]  H CARDONA,et al.  Keratoprosthesis; acrylic optical cylinder with supporting intralamellar plate. , 1962, American journal of ophthalmology.